{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:04:08Z","timestamp":1768550648860,"version":"3.49.0"},"posted":{"date-parts":[[2020,11,16]]},"group-title":"Allergy and Immunology","reference-count":35,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2020,11,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine clinical and ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A retrospective cohort study of healthcare workers who had self-isolated due to COVID-19.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>University Hospitals Birmingham NHS Foundation Trust, UK (UHBFT).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>956 health care workers were recruited by open invitation via UHBFT trust email and social media.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>Participants volunteered a venous blood sample that was tested for the presence of anti-SARS-CoV-2 spike glycoprotein antibodies. Results were interpreted in the context of the symptoms of their original illness and ethnodemographic variables.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Using an assay that simultaneously measures the combined IgG, IgA and IgM response against the spike glycoprotein (IgGAM), the overall seroprevalence within this cohort was 46.2% (n=442\/956). The seroprevalence of immunoglobulin isotypes was 36.3%, 18.7% and 8.1% for IgG, IgA and IgM respectively. IgGAM identified serological responses in 40.6% (n=52\/128) of symptomatic individuals who reported a negative SARS-CoV-2 PCR test. Increasing age, non-white ethnicity and obesity were independently associated with greater IgG antibody response against the spike glycoprotein. Self-reported fever and fatigue were associated with greater IgG and IgA responses against the spike glycoprotein. The combination of fever and\/or cough and\/or anosmia had a positive predictive value of 92.3% for seropositivity.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions and relevance<\/jats:title>\n                  <jats:p>Assays employing combined antibody detection demonstrate enhanced seroepidemiological sensitivity and can detect prior viral exposure even when PCR swabs have been negative. We demonstrate an association between known ethnodemographic risk factors associated with mortality from COVID-19 and the magnitude of serological responses in mild-to-moderate disease. The combination of cough, and\/or fever and\/or anosmia identifies the majority of individuals who should self-isolate for COVID-19.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2020.11.12.20230763","type":"posted-content","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T18:20:19Z","timestamp":1605550819000},"source":"Crossref","is-referenced-by-count":6,"title":["Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-2156","authenticated-orcid":false,"given":"Adrian M","family":"Shields","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian E","family":"Faustini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Perez-Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Jossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel D","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saly","family":"Al-Taei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Backhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynsey","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ebanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beena","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aduragbemi A","family":"Faniyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark I.","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Grinbergs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golaleh","family":"McGinnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David. C","family":"Wraith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam F","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex G","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2020111810400710000_2020.11.12.20230763v1.1","unstructured":"Williamson, E.J. , et al., OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature, 2020."},{"key":"2020111810400710000_2020.11.12.20230763v1.2","unstructured":"Bastard, P. , et al., Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science, 2020. 370(6515)."},{"issue":"10","key":"2020111810400710000_2020.11.12.20230763v1.3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","year":"2020","journal-title":"Nat Med"},{"key":"2020111810400710000_2020.11.12.20230763v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y"},{"issue":"5","key":"2020111810400710000_2020.11.12.20230763v1.5","doi-asserted-by":"crossref","first-page":"100078","DOI":"10.1016\/j.xcrm.2020.100078","article-title":"Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19","volume":"1","year":"2020","journal-title":"Cell Rep Med"},{"key":"2020111810400710000_2020.11.12.20230763v1.6","unstructured":"Eyre, D.W. , et al., Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. Elife, 2020. 9."},{"key":"2020111810400710000_2020.11.12.20230763v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31484-7"},{"key":"2020111810400710000_2020.11.12.20230763v1.8","doi-asserted-by":"crossref","unstructured":"Shields, A. , et al., SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax, 2020.","DOI":"10.1136\/thoraxjnl-2020-215414"},{"key":"2020111810400710000_2020.11.12.20230763v1.9","doi-asserted-by":"crossref","unstructured":"Watanabe, Y. , et al., Site-specific glycan analysis of the SARS-CoV-2 spike. Science, 2020: p. eabb9983.","DOI":"10.1126\/science.abb9983"},{"key":"2020111810400710000_2020.11.12.20230763v1.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"2020111810400710000_2020.11.12.20230763v1.11","unstructured":"Ministry of Housing, C.a.L.G., English indices of deprivation 2019. 2019."},{"key":"2020111810400710000_2020.11.12.20230763v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1985"},{"issue":"6","key":"2020111810400710000_2020.11.12.20230763v1.13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","year":"2020","journal-title":"Nat Med"},{"key":"2020111810400710000_2020.11.12.20230763v1.14","unstructured":"Zhao, J. , et al., Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis, 2020."},{"issue":"9","key":"2020111810400710000_2020.11.12.20230763v1.15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-019-0177-9","article-title":"Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?","volume":"19","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2020111810400710000_2020.11.12.20230763v1.16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","year":"2019","journal-title":"Immun Ageing"},{"key":"2020111810400710000_2020.11.12.20230763v1.17","doi-asserted-by":"publisher","DOI":"10.1086\/520200"},{"key":"2020111810400710000_2020.11.12.20230763v1.18","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00654-15"},{"issue":"1","key":"2020111810400710000_2020.11.12.20230763v1.19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms","volume":"142","year":"2020","journal-title":"Circulation"},{"key":"2020111810400710000_2020.11.12.20230763v1.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.12.4196"},{"key":"2020111810400710000_2020.11.12.20230763v1.21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081571"},{"key":"2020111810400710000_2020.11.12.20230763v1.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.22.2131"},{"key":"2020111810400710000_2020.11.12.20230763v1.23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190344"},{"key":"2020111810400710000_2020.11.12.20230763v1.24","unstructured":"Galv\u00e1n-Rom\u00e1n, J.M. , et al., IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: an observational study. J Allergy Clin Immunol, 2020."},{"key":"2020111810400710000_2020.11.12.20230763v1.25","doi-asserted-by":"crossref","unstructured":"Ward, H. , et al., Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. medRxiv, 2020: p. 2020.08.12.20173690.","DOI":"10.1101\/2020.08.12.20173690"},{"key":"2020111810400710000_2020.11.12.20230763v1.26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fpubh.2020.00418","article-title":"Racial and Gender-Based Differences in COVID-19","volume":"8","year":"2020","journal-title":"Front Public Health"},{"issue":"12","key":"2020111810400710000_2020.11.12.20230763v1.27","doi-asserted-by":"crossref","first-page":"e0225512","DOI":"10.1371\/journal.pone.0225512","article-title":"Establishment of normative ranges of the healthy human immune system with comprehensive polychromatic flow cytometry profiling","volume":"14","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"2020111810400710000_2020.11.12.20230763v1.28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-020-0314-5","article-title":"Dissecting racial disparities in multiple myeloma-clues from differential immunoglobulin levels","volume":"10","year":"2020","journal-title":"Blood Cancer J"},{"key":"2020111810400710000_2020.11.12.20230763v1.29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915133107"},{"key":"2020111810400710000_2020.11.12.20230763v1.30","doi-asserted-by":"crossref","unstructured":"Faustini, S.E. , et al., Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv, 2020: p. 2020.06.16.20133025.","DOI":"10.1101\/2020.06.16.20133025"},{"key":"2020111810400710000_2020.11.12.20230763v1.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3364"},{"key":"2020111810400710000_2020.11.12.20230763v1.32","doi-asserted-by":"crossref","unstructured":"Ra, S.H. , et al., Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax, 2020: p. thoraxjnl-2020-215042.","DOI":"10.1136\/thoraxjnl-2020-215042"},{"key":"2020111810400710000_2020.11.12.20230763v1.33","doi-asserted-by":"crossref","unstructured":"Jamal, A.J. , et al., Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis, 2020.","DOI":"10.1101\/2020.05.01.20081026"},{"issue":"18","key":"2020111810400710000_2020.11.12.20230763v1.34","first-page":"1843","article-title":"Detection of SARS-CoV-2 in Different Types of Clinical Specimens","volume":"323","year":"2020","journal-title":"Jama"},{"key":"2020111810400710000_2020.11.12.20230763v1.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe7828"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2020.11.12.20230763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:58:39Z","timestamp":1768485519000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2020.11.12.20230763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1101\/2020.11.12.20230763","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1136\/bmjresp-2020-000872","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2020,11,16]]},"subtype":"preprint"}}